0000899243-18-024426.txt : 20180913
0000899243-18-024426.hdr.sgml : 20180913
20180913161039
ACCESSION NUMBER: 0000899243-18-024426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180912
FILED AS OF DATE: 20180913
DATE AS OF CHANGE: 20180913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nicholson Garry A
CENTRAL INDEX KEY: 0001640861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 181068993
MAIL ADDRESS:
STREET 1: C/O TESARO, INC.
STREET 2: 1000 WINTER STREET, SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-12
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001640861
Nicholson Garry A
79 T.W. ALEXANDER DRIVE
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
NC
27709
1
0
0
0
Stock Option (right to buy)
65.75
2018-09-12
4
A
0
20000
0.00
A
2028-09-12
Common Stock
20000
20000
D
The stock option will vest in thirty-six monthly installments at the end of each successive month following September 12, 2018, subject to the Reporting Person's continued service as a director.
/s/ J. Stillman Hanson, Attorney-in-fact
2018-09-13